Utah Medical Products (NASDAQ:UTMD - Get Free Report) released its quarterly earnings results on Thursday. The medical instruments supplier reported $0.94 EPS for the quarter, Zacks reports. The firm had revenue of $9.95 million for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.50%.
Utah Medical Products Trading Up 0.8%
Utah Medical Products stock traded up $0.48 during trading on Friday, hitting $58.54. The company had a trading volume of 9,000 shares, compared to its average volume of 16,369. Utah Medical Products has a 1-year low of $51.26 and a 1-year high of $71.96. The company's 50 day simple moving average is $55.92 and its 200-day simple moving average is $56.95. The stock has a market cap of $190.26 million, a price-to-earnings ratio of 15.65 and a beta of 0.28.
Utah Medical Products Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, July 3rd. Investors of record on Monday, June 16th were issued a $0.305 dividend. The ex-dividend date was Monday, June 16th. This represents a $1.22 annualized dividend and a yield of 2.08%. Utah Medical Products's dividend payout ratio (DPR) is presently 32.62%.
Institutional Trading of Utah Medical Products
A hedge fund recently bought a new stake in Utah Medical Products stock. Jane Street Group LLC bought a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 5,653 shares of the medical instruments supplier's stock, valued at approximately $317,000. Jane Street Group LLC owned about 0.17% of Utah Medical Products as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 69.60% of the company's stock.
About Utah Medical Products
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
